Targeting DNA Damage Repair and Immune Checkpoint Proteins for Optimizing the Treatment of Endometrial Cancer

The dependence of cancer cells on the DNA damage response (DDR) pathway for the repair of endogenous- or exogenous-factor-induced DNA damage has been extensively studied in various cancer types, including endometrial cancer (EC). Targeting one or more DNA damage repair protein with small molecules h...

Full description

Bibliographic Details
Published in:	Pharmaceutics
Main Authors:	Xing Bian, Chuanbo Sun, Jin Cheng, Bo Hong
Format:	Article
Language:	English
Published:	MDPI AG 2023-08-01
Subjects:	endometrial cancer DNA damage repair PARP immunotherapy
Online Access:	https://www.mdpi.com/1999-4923/15/9/2241

Similar Items

Therapeutic Targeting of DNA Damage Repair in the Era of Precision Oncology and Immune Checkpoint Inhibitors
by: Curtis A. Clark, et al.
Published: (2023-01-01)

PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells
by: Linglong Yin, et al.
Published: (2018-07-01)

DNA damage repair protein PARP1 poly (ADP-ribosyl) ates mitotic protein BUB3 regulates mitosis in HeLa cells
by: YANG Xue, et al.
Published: (2023-08-01)

Therapeutic targeting of PARP with immunotherapy in acute myeloid leukemia
by: Xing Bian, et al.
Published: (2024-08-01)

DNA Damage Repair and Current Therapeutic Approaches in Gastric Cancer: A Comprehensive Review
by: Menghui Wang, et al.
Published: (2022-08-01)

Serine is the major residue for ADP-ribosylation upon DNA damage
by: Luca Palazzo, et al.
Published: (2018-02-01)

Alkannin-Induced Oxidative DNA Damage Synergizes With PARP Inhibition to Cause Cancer-Specific Cytotoxicity
by: Mingxin Chang, et al.
Published: (2020-12-01)

Antitumor activity of rucaparib plus PLX038A in serous endometrial carcinoma
by: Xiaonan Hou, et al.
Published: (2025-05-01)

Harnessing DNA Repair Defects to Augment Immune-Based Therapies in Triple-Negative Breast Cancer
by: Curtis A. Clark, et al.
Published: (2021-09-01)

Multifaceted Role of PARP-1 in DNA Repair and Inflammation: Pathological and Therapeutic Implications in Cancer and Non-Cancer Diseases
by: Simonetta Pazzaglia, et al.
Published: (2019-12-01)

Association between DNA damage repair gene somatic mutations and immune‐related gene expression in ovarian cancer
by: Wenjuan Tian, et al.
Published: (2020-03-01)

RAD21 Confers Poor Prognosis and Affects Ovarian Cancer Sensitivity to Poly(ADP-Ribose)Polymerase Inhibitors Through DNA Damage Repair
by: Rui Gou, et al.
Published: (2022-07-01)

Prediction of immune infiltration and prognosis for patients with urothelial bladder cancer based on the DNA damage repair-related genes signature
by: Tianhang Li, et al.
Published: (2023-03-01)

Characterization of DNA damage repair pathway utilization in high-grade serous ovarian cancers yields rational therapeutic approaches
by: Erika Nakatsuka, et al.
Published: (2024-12-01)

DNA Repair Inhibitors: Potential Targets and Partners for Targeted Radionuclide Therapy
by: Honoka Obata, et al.
Published: (2023-07-01)

A Review on DNA Repair Inhibition by PARP Inhibitors in Cancer Therapy
by: Shah Ashish P., et al.
Published: (2018-03-01)

The mechanism and clinical application of DNA damage repair inhibitors combined with immune checkpoint inhibitors in the treatment of urologic cancer
by: Deqian Xie, et al.
Published: (2023-05-01)

Clinical outcomes of DNA-damaging agents and DNA damage response inhibitors combinations in cancer: a data-driven review
by: Rick Fontenot, et al.
Published: (2025-06-01)

Complex DNA repair pathways as possible therapeutic targets to overcome temozolomide resistance in glioblastoma
by: Koji eYoshimoto, et al.
Published: (2012-12-01)

DNA Damage Repair in Brain Tumor Immunotherapy
by: Shihong Zhao, et al.
Published: (2022-01-01)

BRCA1 in the DNA damage response and at telomeres
by: Eliot Michael Rosen
Published: (2013-06-01)

The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy
by: Congqi Shi, et al.
Published: (2022-09-01)

Clinicopathologic significance of DNA mismatch repair protein status in endometrial cancer
by: Ju-Hyun Kim, et al.
Published: (2022-05-01)

Chromatin Trapping of Factors Involved in DNA Replication and Repair Underlies Heat-Induced Radio- and Chemosensitization
by: Artem V. Luzhin, et al.
Published: (2020-06-01)

Targeting PARP1 to Enhance Anticancer Checkpoint Immunotherapy Response: Rationale and Clinical Implications
by: Carlos Wagner S. Wanderley, et al.
Published: (2022-04-01)

Beyond DNA repair: the novel immunological potential of PARP inhibitors
by: Roman M. Chabanon, et al.
Published: (2019-03-01)

DNA damage repair-related methylated genes RRM2 and GAPDH are prognostic biomarkers associated with immunotherapy for lung adenocarcinoma
by: Xinru Mao, et al.
Published: (2025-05-01)

Resolving DNA Damage: Epigenetic Regulation of DNA Repair
by: Panagiotis Karakaidos, et al.
Published: (2020-05-01)

Functions of PARylation in DNA Damage Repair Pathways
by: Huiting Wei, et al.
Published: (2016-06-01)

Development and validation of a novel DNA damage repair-related long non-coding RNA signature in predicting prognosis, immunity, and drug sensitivity in uterine corpus endometrial carcinoma
by: Tao Wang, et al.
Published: (2023-01-01)

Research progress on the role and mechanism of DNA damage repair in germ cell development
by: Yan Wang, et al.
Published: (2023-07-01)

PARP‐1 regulates DNA repair factor availability
by: Matthew J Schiewer, et al.
Published: (2018-11-01)

DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair
by: Yousef Khazaei Monfared, et al.
Published: (2023-12-01)

Atox1 promotes CRC progression by protecting DNA damage through interacts with a novel copper-binding protein PARP1
by: Mingming Sun, et al.
Published: (2026-03-01)

DNA damage and repair: underlying mechanisms leading to microcephaly
by: Jessica Honorato Ribeiro, et al.
Published: (2023-10-01)

Aldehyde-induced DNA-protein crosslinks- DNA damage, repair and mutagenesis
by: Thomas Blouin, et al.
Published: (2024-09-01)

Augmented antitumor activity by olaparib plus AZD1775 in gastric cancer through disrupting DNA damage repair pathways and DNA damage checkpoint
by: Xiaoting Lin, et al.
Published: (2018-06-01)

PRDX1 Counteracts Catastrophic Telomeric Cleavage Events That Are Triggered by DNA Repair Activities Post Oxidative Damage
by: Wareed Ahmed, et al.
Published: (2020-11-01)

The Role of DNA Damage and Repair in Idiopathic Pulmonary Fibrosis
by: Jiahui Zhu, et al.
Published: (2022-11-01)

Advanced endometrial cancer—The next generation of treatment: A society of gynecologic oncology journal club clinical commentary
by: Todd Tillmanns, et al.
Published: (2024-10-01)